Published in partnership with the

Logo

Club Jules Gonin

Vitreous prolapse and IOL dislocation during intravitreal injection of triamcinolone acetonide

Robert F. Degenring and Gangolf Sauder

View Related Documents

Abstract

Background  

To report on procedure-related anterior segment complications during intravitreal injections.

Methods  

In a prospective interventional case series, 614 eyes received a total of 723 intravitreal injections of about 20 mg triamcinolone acetonide (in 0.2 ml) after paracentesis and aqueous humor drainage for various indications.

Results  

In three eyes (0.49% of all eyes) a vitreous prolapse occurred during the injection. In one eye, the vitreous prolapse was combined with dislocation of the intraocular lens (IOL). All three eyes were pseudophakic, showing an posterior capsule defect, and the IOL located in the ciliary sulcus. They were treated by translimbal vitrectomy, and one eye with reposition of the IOL. No other procedure-related postoperative complications were observed during injection or follow-up (7.8±7.1 months).

Conclusions  

Intravitreal injections may cause a vitreous prolapse into the anterior chamber with or without IOL decentration or dislocation in predisposed eyes. Ophthalmologists should be aware of this possible complication and inform patients at risk.

Keywords  Intravitreal injection - Anterior chamber - Intraocular lens dislocation - Vitreous prolapse - Triamcinolone acetonide - Complications

None of the authors received any financial support, or had any financial interest.

Fulltext Preview

Image of the first page of the fulltext document